- Adjust your mawashi! It's Big Pharma Europe vs US II, Sumo-style
- When Can You Ban Parallel Trade?
- Pharma sounds alarm over Grexit threats
- US Capitol Capsule: Caution biopharma: wacky Washington wild ride ahead
- Executive profile: Genzyme's CEO on dark times, transition and the long view
- The EMA at 20: Guido Rasi looks at how the EU regulatory landscape might change over the next decade